Key Chemical Building Blocks for Drug Discovery: Focus on CAS 73963-42-5
The relentless pursuit of novel therapeutics in drug discovery hinges on the availability of versatile and high-quality chemical building blocks. These molecular components are the foundational elements from which potential drug candidates are constructed, enabling researchers to explore new chemical spaces and design molecules with specific biological activities. Among these critical building blocks, 1-Cyclohexyl-5-(4-chlorobutyl)-1H-tetrazole, identified by its CAS number 73963-42-5, plays a pivotal role, particularly in the pharmaceutical industry.
This specific compound is recognized for its crucial function as an intermediate in the synthesis of Cilostazol, a widely used medication for peripheral artery disease. The unique structure of 1-Cyclohexyl-5-(4-chlorobutyl)-1H-tetrazole, combining a cyclohexyl group, a tetrazole ring, and a reactive chlorobutyl chain, makes it an ideal starting material for constructing the complex molecular architecture of Cilostazol. The reliable synthesis of this intermediate, often with high yields approaching 93%, ensures that drug manufacturers have access to a consistent supply of this essential component.
For drug discovery programs, sourcing these building blocks efficiently and with guaranteed quality is paramount. China has become a global leader in the production of fine chemicals and pharmaceutical intermediates, with numerous manufacturers offering compounds like 1-Cyclohexyl-5-(4-chlorobutyl)-1H-tetrazole. These suppliers typically provide products with purity levels exceeding 95%, catering to the stringent demands of the pharmaceutical sector. Partnering with these reputable Chinese manufacturers allows research institutions and pharmaceutical companies to obtain necessary chemical building blocks for drugs, thereby accelerating the drug discovery process. The availability of such intermediates, backed by robust manufacturing capabilities, is fundamental to advancing medical science and bringing new treatments to patients. The strategic sourcing of these vital compounds from reliable sources is a hallmark of successful drug development.
This specific compound is recognized for its crucial function as an intermediate in the synthesis of Cilostazol, a widely used medication for peripheral artery disease. The unique structure of 1-Cyclohexyl-5-(4-chlorobutyl)-1H-tetrazole, combining a cyclohexyl group, a tetrazole ring, and a reactive chlorobutyl chain, makes it an ideal starting material for constructing the complex molecular architecture of Cilostazol. The reliable synthesis of this intermediate, often with high yields approaching 93%, ensures that drug manufacturers have access to a consistent supply of this essential component.
For drug discovery programs, sourcing these building blocks efficiently and with guaranteed quality is paramount. China has become a global leader in the production of fine chemicals and pharmaceutical intermediates, with numerous manufacturers offering compounds like 1-Cyclohexyl-5-(4-chlorobutyl)-1H-tetrazole. These suppliers typically provide products with purity levels exceeding 95%, catering to the stringent demands of the pharmaceutical sector. Partnering with these reputable Chinese manufacturers allows research institutions and pharmaceutical companies to obtain necessary chemical building blocks for drugs, thereby accelerating the drug discovery process. The availability of such intermediates, backed by robust manufacturing capabilities, is fundamental to advancing medical science and bringing new treatments to patients. The strategic sourcing of these vital compounds from reliable sources is a hallmark of successful drug development.
Perspectives & Insights
Data Seeker X
“This specific compound is recognized for its crucial function as an intermediate in the synthesis of Cilostazol, a widely used medication for peripheral artery disease.”
Chem Reader AI
“The unique structure of 1-Cyclohexyl-5-(4-chlorobutyl)-1H-tetrazole, combining a cyclohexyl group, a tetrazole ring, and a reactive chlorobutyl chain, makes it an ideal starting material for constructing the complex molecular architecture of Cilostazol.”
Agile Vision 2025
“The reliable synthesis of this intermediate, often with high yields approaching 93%, ensures that drug manufacturers have access to a consistent supply of this essential component.”